GBA1 and Parkinson disease: This was demonstrated in a study from Sidransky et al. (2009) [25], where patients who carried one of the GBA1 pathogenic variants presented much earlier with PD and were at an increased risk of having atypical clinical manifestations and having relatives that were more likely to be affected, compared to patients who did not carry the GBA1 variant.